In HNSCC patients, pyrimethamine achieves potent DHFR inhibition and a favorable safety profile supporting a future phase 2 trial integrating pyrimethamine with definitive radiation-based therapy for NRF2-active HNSCCs.
Abstract
Purpose
NRF2 hyperactivity is associated with radiation resistance in head and neck squamous cell carcinoma (HNSCC). We evaluated the dihydrofolate reductase (DHFR) inhibitors pyrimethamine and its potent analog, WCDD115, as radiosensitizing agents through disruption of one-carbon metabolism.
PATIENTS AND
Methods
Preclinical studies used NRF2-competent and deficient HNSCC models, clonogenic assays, transcriptomics, metabolomics, pharmacokinetics/toxicity testing, and syngeneic tumor grafts to assess WCDD115 as a novel radiosensitizing agent. In parallel, we conducted an open-label, single-center, window-of-opportunity early phase I clinical trial (NCT05678348) of previously untreated patients with HPV(-) stage III/IV HNSCC to receive pyrimethamine 50mg prior to surgery. Correlative analysis included mass spectrometry, western blotting, and pathway analysis.
Results
WCDD115 enhanced radiation-induced DNA damage and suppressed one-carbon metabolism and nucleotide biosynthesis. Parallel mouse tumor studies demonstrated that WCDD115 enhanced the efficacy of radiation in NRF2-competent but not NRF2-deficient tumors. In a clinical trial of neoadjuvant pyrimethamine, DHFR protein expression was enriched post-treatment by a mean fold change of 9.91 (95% confidence interval 8.1 to 12.2), consistent with a strong on-target effect. The drug was well tolerated with no drug-related grade 3-5 adverse events or surgical delays.
Conclusions
NRF2 hyperactivity is associated with enhanced one-carbon metabolism which can be therapeutically targeted with DHFR inhibitors to promote radiation sensitization. In HNSCC patients, pyrimethamine achieves potent DHFR inhibition and a favorable safety profile supporting a future phase 2 trial integrating pyrimethamine with definitive radiation-based therapy for NRF2-active HNSCCs.
The comparison of adopter and non-adopter sample reveals three potential adoption inhibitor, security, data privacy, and portability, which underlines the importance of the technical and security perspectives for research investigating the adoption of technology.
Nattakarn Phaphoom, Xiaofeng Wang, S. Samuel et al.· Journal of Systems and Softw...· 111 citations· ⚡8
This study investigates how Lean internal startup facilitates software product innovation in large companies and identifies its enablers and inhibitors, and shows the potential of the method-in-action framework to investigate the Lean startup approach in non-startup context.
Henry Edison, Nina M. Smørsgård, Xiaofeng Wang et al.· Journal of Systems and Softw...· 78 citations· ⚡6
This paper highlights the challenges to conduct proper affect-related studies with psychology, provides a comprehensive literature review in affect theory, and proposes guidelines for conducting psychoempirical software engineering.
D. Graziotin, Xiaofeng Wang, P. Abrahamsson· SSE@SIGSOFT FSE· 56 citations· ⚡4
This study conducts a multiple case study on twenty European software startups and proposes a prototype-centric learning model in early stage software startups, and identifies factors that occur as barriers but also facilitators for prototyping in earlystage software startups.
Anh Nguyen-Duc, Xiaofeng Wang, P. Abrahamsson· International Conference on...· 44 citations· ⚡5
It is demonstrated that linker-free PROTACs can outperform traditional designs, marking a paradigm shift in PROTAC development for targeted protein degradation.
Pinal, a 16-billion-parameter foundation model that produces protein candidates from natural-language functional descriptions, supports natural language as a high-level interface for candidate generation in protein design, enabling programmable exploration with reduced reliance on manually specified structural or seque...
A new machine-learning framework aims to improve the success rate of computational protein design while moving away from results that reproduce sequences found in nature.